指南与共识妇科

妇科癌症女性遗传学服务的多学科峰会:妇科肿瘤学会白皮书

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
指南 / 共识 · Gynecol Oncol · 2017-06-07

妇科肿瘤学会(SGO)召集多学科峰会,讨论遗传检测服务模式、障碍与教育机会。小组认可SGO、NCCN和NSGC现有遗传检测指南,识别三个未满足需求领域,并形成行动计划以弥补教育和服务缺口。

要点

  • 小组认可SGO、NCCN和NSGC对卵巢、输卵管、腹膜癌或DNA错配修复缺陷子宫内膜癌女性的遗传检测指南。
  • 识别三个未满足需求:卵巢、输卵管、腹膜癌女性的及时普遍遗传检测;遗传咨询和检测最低标准的教育;受检者检测及家属级联检测的实施障碍。
  • 多学科共识形成行动计划,以解决妇科肿瘤提供者教育和癌症遗传学服务提供的缺口。

核心结论

  • 小组认可当前SGO、NCCN和NSGC对卵巢、输卵管、腹膜癌或DNA错配修复缺陷子宫内膜癌女性的遗传检测指南。
  • 识别三个未满足需求领域:卵巢、输卵管、腹膜癌女性的及时普遍遗传检测;遗传咨询和检测最低标准的教育;受检者检测及家属级联检测的实施障碍。
  • 所有利益相关方达成共识,形成行动计划以解决妇科肿瘤提供者教育和癌症遗传学服务提供的缺口。

研究设计与样本

  • 妇科肿瘤学会(SGO)组织多学科峰会,参与者包括美国妇产科医师学会(ACOG)、美国临床肿瘤学会(ASCO)、国家遗传咨询师学会(NSGC)以及患者倡导组织BrightPink和FORCE的代表。
  • 讨论三个主题领域:遗传检测的服务提供模式、遗传检测的障碍、遗传检测提供者的教育机会。

主要发现

  • 小组认可当前SGO、NCCN和NSGC对卵巢、输卵管、腹膜癌或DNA错配修复缺陷子宫内膜癌女性的遗传检测指南。
  • 识别三个未满足需求领域:卵巢、输卵管、腹膜癌女性的及时普遍遗传检测;遗传咨询和检测最低标准的教育;受检者检测及家属级联检测的实施障碍。

关键数值与推荐

  • 认可SGO、NCCN和NSGC对卵巢、输卵管、腹膜癌或DNA错配修复缺陷子宫内膜癌女性的遗传检测指南。
  • 未满足需求包括卵巢、输卵管、腹膜癌女性的及时普遍遗传检测。
  • 未满足需求包括遗传咨询和检测最低标准的教育。
  • 未满足需求包括受检者检测及家属级联检测的实施障碍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess current practice, advise minimum standards, and identify educational gaps relevant to genetic screening, counseling, and testing of women affected by gynecologic cancers. METHODS: The Society of Gynecologic Oncology (SGO) organized a multidisciplinary summit that included representatives from the American College of Obstetricians and Gynecologists (ACOG), the American Society Clinical Oncology (ASCO), the National Society of Genetic Counselors (NSGC), and patient advocacy groups, BrightPink and Facing our Risk of Cancer Empowered (FORCE). Three subject areas were discussed: care delivery models for genetic testing, barriers to genetic testing, and educational opportunities for providers of genetic testing. RESULTS: The group endorsed current SGO, National Comprehensive Cancer Network (NCCN), and NSGC genetic testing guidelines for women affected with ovarian, tubal, peritoneal cancers, or DNA mismatch repair deficient endometrial cancer. Three main areas of unmet need were identified: timely and universal genetic testing for women with ovarian, fallopian tube, and peritoneal cancers; education regarding minimum standards for genetic counseling and testing; and barriers to implementation of testing of both affected individuals as well as cascade testing of family members. Consensus building among all stakeholders resulted in an action plan to address gaps in education of gynecologic oncology providers and delivery of cancer genetics care.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Randall LM, Pothuri B, Swisher EM, et al. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper. Gynecol Oncol. 2017. PMID: 28596016. doi:10.1016/j.ygyno.2017.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。